Eastman Chemical EMN Chemical Intermediates — Asset Impairment Charges

Discontinued — last reported Q4 '21

Similar metrics at other companies

PSXChemicals — Impairments

$0—

DOWImpairment Charges

$27M-87.0%

LYBImpairment Charges

$15M—

WESImpairment Charges

$608K+20,167%

ORAImpairment Charges

$8.11M—

ARImpairment Charges

$948K-83.1%

Other financials

Income statement

See full

Revenue$2.2B-4.9%

Gross profit$431.0M-24.0%

Net income$107.0M-41.2%

EPS (diluted)$0.93-40.8%

Balance sheet

See full

Cash & equivalents$665.0M+59.1%

Total debt$5.2B+4.0%

Total equity$6.0B+2.4%

Total assets$15.2B+1.7%

Cash flow

See full

Operating cash flow-$137.0M+18.0%

CapEx$103.0M-29.9%

Free cash flow-$240.0M+23.6%

Valuation

See full

Market cap$8.29B-14.2%

Enterprise value$12.84B-10.1%

P/E20.8×+10.3×

P/S1×-0.1×

Profitability

See full

Gross margin19.8%-5.1pp

Operating margin16%—

Net margin4.6%-5.2pp

FCF margin5.8%-0.4pp

Returns & leverage

See full

Return on equity6.7%-9.4pp

Debt / equity0.9×0.0×

Current ratio1.5×-0.3×

Where this comes from

Reported directly by Eastman Chemical in its filing.

Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.

The official record: Eastman Chemical’s 10-K, filed February 14, 2024, on SEC EDGAR. View the filing →

Ask your AI about Eastman Chemical's chemical intermediates — asset impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eastman Chemical's chemical intermediates — asset impairment charges?: Eastman Chemical (EMN) reported chemical intermediates — asset impairment charges of $500K in Q4 2021.
What does chemical intermediates — asset impairment charges mean?: This metric represents non-cash charges taken by the Chemical Intermediates segment to reduce the carrying value of tangible or intangible assets that are no longer expected to provide future economic benefits. It signals that the segment's assets are overvalued relative to their current market or operational utility. Frequent impairments may suggest poor capital allocation or deteriorating market conditions.